BIO MARKERS IN CANCER DIAGNOSIS AND TREATMENT
#1

Presented BY
T.G.V HARISH BHOOPATI

[attachment=9855]
BIO MARKERS IN CANCER DIAGNOSIS AND TREATMENT
Biomarker [1]
Definition:

• It is a characteristic which indicates a normal or abnormal process.
• It is a pharmacological response which indicates the effectiveness of a specific drug.
• It’s a biological molecule which indicates either a condition or disease state.
• It may be:
– Protein
– Nucleic acid
– Carbohydrate
– lipid
Biomarker & Diagnosis
Ideal Marker for diagnosis

– Should have great sensitivity, specificity, and accuracy in reflecting total disease burden. A tumor marker should also be prognostic of outcome and predictive of tumor recurrence and effectiveness of anti-cancer treatment.
– Biomarker for Screening
– The marker must be highly specific, minimize false positive and negative
– The marker must be able to clearly reflect the early stage of disease
– The method for screening should be cost effective
– Samples for biomarker detection
– Blood, urine, or other body fluids samples
– Biomarker Validation
CLASSIFICATION OF BIO MARKERS
• Common Biomarker for Cancer diagnosis
(diagnostic markers)
• Common Biomarker for Cancer diagnosis
• Common Biomarker for Cancer diagnosis
• Prostate Cancer marker PSA
• Beta-2-microglobulin (b2M)
OTHER EXAMPLES OF PREDICTIVE BIO-MARKERS
• Breast Cancer
– ER/PR ® tamoxifen
– HER2 ® trastuzumab
– Lymphoma
– CD20 ® rituximab
– Gastrointestinal stromal tumor
– C-kit ® imatinib, sunitinib
• Bio-markers as Targets for Therapy (FDA-approved therapies for solid tumors)
• Extracellular targets
– EGFR/HER (cetuximab, panitumumab, trastuzumab)
– VEGF (bevacizumab)
– HER2 (trastuzumab)
• Intracellular targets
– EGFR (erlotinib)
– VEGFR (sorafenib, sunitinib)
– mTOR (temsirolimus)
– PDGFR (sorafenib, sunitinib)
– RAF/MAP kinase (sorafenib)
– HER2/EGFR1 (lapatinib)
– C-kit (sunitinib)
Therapies Target Biomarkers
• Simply target the biomarker by antibody.
• Therapeutic agent page link to a targeting moiety that target to bio-marker.
• Basic requirement: the marker must presented on cell surface.
• Ideally:
– The interaction is highly specific
– If the target accumulation is high then it is a good agent
• Therapy Target Her-2
• Therapy Target PSMA
• Biomarker & Targeted Imaging
• Imaging Targeting PSMA
• Imaging Targeting PSMA
CONCLUSION
• Bio-markers play an important role in cancer diagnosis.
• They help in finding new targets to cure cancer.
• They laid a new way in early diagnosis of cancer.
• Investigations has to be done, to develop bio-markers as reliable diagnostic and therapeutic target.
Reply
#2
can u please upload a presentation or documentation on "Bio markers in cancer diagnosis and treatment"
Reply

Important Note..!

If you are not satisfied with above reply ,..Please

ASK HERE

So that we will collect data for you and will made reply to the request....OR try below "QUICK REPLY" box to add a reply to this page
Popular Searches: treatment of cancer using nanotechnology seminar report, boron chemistry and applictions to cancer treatment, new technology for cancer treatment, borane chemistry and it s applications in treatment of cancer, nanotechnology and cancer treatment abstract, powered by article dashboard new drug treatment for cancer, boron chemistry and it s application for treatment of cancer,

[-]
Quick Reply
Message
Type your reply to this message here.

Image Verification
Please enter the text contained within the image into the text box below it. This process is used to prevent automated spam bots.
Image Verification
(case insensitive)

Forum Jump: